LGHT vs. PJP ETF Comparison

Comparison of Langar Global HealthTech ETF (LGHT) to PowerShares Dynamic Pharmaceuticals (PJP)
LGHT

Langar Global HealthTech ETF

LGHT Description

LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.

Grade (RS Rating)

Last Trade

$10.35

Average Daily Volume

915

Number of Holdings *

31

* may have additional holdings in another (foreign) market
PJP

PowerShares Dynamic Pharmaceuticals

PJP Description The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$85.61

Average Daily Volume

8,329

Number of Holdings *

25

* may have additional holdings in another (foreign) market
Performance
Period LGHT PJP
30 Days -1.96% -2.45%
60 Days -2.17% -2.57%
90 Days -1.81% -2.28%
12 Months 23.04%
0 Overlapping Holdings
Symbol Grade Weight in LGHT Weight in PJP Overlap
LGHT Overweight 31 Positions Relative to PJP
Symbol Grade Weight
ISRG A 15.39%
GEHC D 8.56%
RMD C 6.71%
IQV F 6.34%
DXCM C 5.51%
PODD C 5.26%
VEEV C 5.15%
PHG C 4.87%
ZBH C 3.57%
BNTX C 3.53%
ALGN D 2.85%
MASI B 2.46%
DOCS C 2.06%
MRNA F 1.72%
PRCT B 1.27%
ALKS C 0.66%
TNDM D 0.54%
IRTC C 0.44%
PRVA C 0.44%
OMCL C 0.42%
LFST B 0.31%
TDOC C 0.28%
PGNY F 0.25%
EVH F 0.22%
SDGR C 0.21%
GDRX F 0.2%
ALHC C 0.2%
PHR F 0.17%
ACCD D 0.07%
MODV C 0.03%
TBRG B 0.03%
LGHT Underweight 25 Positions Relative to PJP
Symbol Grade Weight
ABT B -5.77%
JNJ C -5.29%
CORT B -5.29%
AMGN F -5.13%
PFE F -5.12%
ABBV F -4.91%
MRK D -4.79%
LLY F -4.67%
BMY B -4.07%
GILD C -4.0%
PBH A -3.82%
PCRX C -3.78%
UTHR C -3.7%
REGN F -3.69%
LGND C -3.63%
JAZZ B -3.62%
VTRS A -3.61%
AMRX C -3.55%
SUPN C -3.47%
INVA D -3.37%
ANIP F -3.12%
AMPH F -3.11%
PRGO C -3.08%
BIIB F -2.71%
GERN D -2.66%
Compare ETFs